Imaging brain tumor proliferative activity with [124I]iododeoxyuridine

Cancer Research

Volumn 60, Issue 3, 2000, Pages 624-635

  Blasberg, Ronald G ^a   Roelcke, Ulrich ^b   Weinreich, Regin ^b   Beattie, Bradley ^a   Von Ammon, Klaus ^c   Yonekawa, Yasuhiro ^c   Landolt, Hans ^d   Guenther, Ilonka ^b   Crompton, Nigel E A ^b   Vontobel, Peter ^b   Missimer, John ^b   Maguire, Ralph P ^b   Koziorowski, Jacek ^b   Knust, E Joachim ^e   Finn, Ronald D ^a   Leenders, Klaus L ^b  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b PAUL SCHERRER INSTITUTE   (Switzerland)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^d CANTONAL HOSPITAL AARAU   (Switzerland)

^e UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

IDOXURIDINE; IODINE 124;

ADULT; AGED; ARTICLE; BRAIN SCINTISCANNING; BRAIN TUMOR; CELL PROLIFERATION; CLINICAL ARTICLE; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DISEASE ACTIVITY; FEMALE; GLIOMA; HUMAN; MALE; MENINGIOMA; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL;

ADULT; AGED; BRAIN; BRAIN NEOPLASMS; CELL DIVISION; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; IDOXURIDINE; IODINE RADIOISOTOPES; KIDNEY; MALE; MIDDLE AGED;

EID: 18544401545     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Ogawa, T., Uemura, K., Shishido, F., et al. Changes of cerebral blood flow and oxygen and glucose metabolism following radiochemotherapy of gliomas: a PET study. J. Comput. Assisted Tomogr., 12: 290-297, 1988.
2. Rozental, J. M., Levine, R. L., Nickles, R. J., and Dobkin, J. A. Glucose uptake by gliomas after treatment. A positron emission tomographic study. Arch. Neurol., 46: 1302-1307, 1989.
3. Mineura, K., Yasuda, T., Kowada, M., Ogawa, T., Shishido, F., and Uemura, K. Positron emission tomographic evaluation of radiochemotherapeutic effect on regional cerebral hemocirculation and metabolism in patients with gliomas. J. Neuro-Oncol., 5: 277-285, 1987.
4. 11C]thymidine. Proc. Natl. Acad. Sci. USA, 69: 988-992, 1972.
5. 3H]thymidine uptake in rodent and canine neoplasms. J. Nucl. Med., 22: 869-874, 1981.
6. Shields, A. F., Lim, K., Grierson, J., Link, J., and Krohn, K. A. Utilization of labeled thymidine in DNA synthesis: studies for PET. J. Nucl. Med., 31: 337-342, 1990.
7. 11C]thymidine PET imaging studies: compartmental model and mathematical analysis. J. Nucl. Med., 39: 1043-1055, 1998.
8. Meikle, S. R., Matthews, J. C., Cunningham, V. J., et al. Parametric image reconstruction using spectral analysis of PET projection data. Phys. Med. Biol., 43(3): 651-666, 1998.
9. 131I]iododeoxyuridine. J. Nucl. Med., 35: 1407-1417, 1994.
10. Macapinlak, H. A., Scott, A. M., Zhang, J., Kalaigian, H., Yeh, S. D. J., Blasberg, R., DeLaPaz, R., DiResta, G., Goldsmith, S. J., Abdel-Dayem, H. M., Castellino, R., and Larson, S. M. Comparison of T1-201 SPECT and F-18 FDG PET images with MRI in the evaluation of primary CNS lymphoma in non-AIDS patients. J. Nucl. Med., 34: 56P, 1993.
11. 2 targets. Appl. Radiat. Isotopes, in press, 2000.
12. 124I. J. Radioanal. Nucl. Chem., 213: 253-261, 1996.
13. 124I]iodo-2′-deoxyuridine for functional PET imaging of cell proliferation. Nucl. Med. Biol. 25: 359-365, 1998.
14. Pelizzari, C. A., Chen, C. T., Spelbring, D. R., and Weichselbaum, R. R. Accurate three dimensional registration of CT, PET, and/or MR images of the brain. J. Comput. Assisted Tomogr., 13: 20-26, 1989.
15. Guenther, I., Psylla, M., Reddy, G. N., Antonini, A., Vontobel, P., Reist, H. W., Zollinger, A., Nickles, R. J., Beer, H. F., Schubiger, P. A., and Leenders, K. L. Positron emission tomography in drug evaluation: influence of three different catechol-O-methyltransferase inhibitors on metabolism of [NCA]6-[18F]fluoro-L-dopa in Rhesus monkey. Nucl. Med. Biol., 22: 921-927, 1995.
16. Prusoff, W., Jaffe, J., and Gunther, H. Studies in the mouse of the pharmacology of 5-iododeoxyuridine, an analogue of thymidine. Biochem Phamacol., 3: 110-121, 1960.
17. Tjuvajev, J., Muraki, A., Ginos, J., Beattie, B., Berk, J., Koutcher, J., Ballon, D., Finn, R., Daghighian, F., and Blasberg, R. Iododeoxyuridine (IUDR) uptake and retention as a measure of tumor growth. J. Nucl. Med., 34: 1152-1161, 1993.
18. Woodard, H. Q., Gigler, R. E., Freed, B., and Russ, G. Expression of tissue isotope distribution. J. Nucl. Med., 16: 958-959, 1975.
19. Zasadny, K. R., and Wahl, R. L. Standardized uptake values of normal tissues at PET with 2-[fluorine-18]-fluoro-2-deoxy-D-glucose: variations with body weight and a method for correction. Radiology, 189: 847-850, 1993.
20. Keyes, J. W. SUV. Standard Uptake or Silly Useless Value? J. Nucl. Med., 36: 1836-1839, 1995.
21. Begg, A. C., McNally, N. J., Shrieve, D. C., and Kärcher, H. A method to measure the duration of the DNA synthesis and the potential doubling time from a single sample. Cytometry, 6: 620-626, 1985.
22. Schwyn, U., Crompton, N. E. A., Blattmann, H., Hauser, B., Klink, B., Parvis, A., Ruslander, D., and Kaser-Hotz, B. Potential tumor doubling time: determination of Tpot for various canine and feline tumors. Vet. Res. Commun., 22: 233-247, 1998.
23. Roelcke, U., Radü, E. W., von Ammon, K., Hausmann, O., Maguire, R. P., and Leenders, K. L. Alteration of blood-brain barrier in human brain tumors: comparison of F-18-fluorodeoxyglucose, C-11-methionine, and rubidium-82 using PET. J. Neuro. Sci., 132: 20-27, 1995.
24. Schuhmacher, J., Kampmann, H., Mattern, J., Volm, M., et al. Incorporation of 131 Iododeoxyuridine into DNA of tumor-bearing rats after partial synchronization as a tool in scintigraphic tumor localization. Nucl. Med., 12: 309-319, 1974.
25. 131I-5-iodo-2-deoxyuridine by malignant tumors in man. Br. J. Cancer, 63: 134-135, 1991.
26. Burger, P. C., Vogel, F. S., and Green, S. B. Glioblastoma multiforme and anaplastic astrocytoma. Pathologic criteria and prognostic implications. Cancer (Phila.), 56: 1106-1111, 1987.
27. Burger, P. G., and Green, S. B. Patient age, histological features and length of survival in patients with glioblastoma multiforme. Cancer (Phila.), 59: 1617-1625, 1987.
28. Di Chiro, G., Brooks, R. A., Patronas, N. J., et al. Issues in the in vivo measurement of glucose metabolism of human central nervous system tumors. Ann. Neurol., 15(S): 138-146, 1984.
29. DiChiro, G., and Brooks, R. A. PET quantitation: blessing and curse. J. Nucl. Med., 29: 1603-1604, 1988.
30. Calabresi, P., Cardoso, S., Finch, S., Kligerman, M., et al. Initial clinical studies with 5-iodo-2′-deoxyuridine. Cancer Res., 21: 550-559, 1961.
31. Lee, D., Prensky, W., Krause, G., and Hughes, W. Blood thymidine level and iododeoxyuridine incorporation and reutilization in DNA in mice given long-acting thymidine pellets. Cancer Res., 36: 4577-4583, 1973.
32. 11C-thymidine positron emission tomography (PET). Proc. Annu. Meet. Am. Soc. Clin. Oncol., 9: A357, 1990.
33. Shields, A. F., Graham, M. M., Kozawa, S. M., and et al. Contribution of labeled carbon dioxide to PET imaging of carbon-11 labeled compounds. J. Nucl. Med., 33: 581-584, 1992.
34. Vander Borght, T., Pauwels, L., Lambotte, D., Labar, D., De Maeght, S., Stroobandt, G., and Laterre, C. Brain tumor imaging with PET and 2-[carbon-11]thymidine. J. Nucl. Med., 35: 974-982, 1994.
35. Gjedde, A. Labeled carbon dioxide: how transient a metabolite. J. Nucl. Med., 32: 585-586, 1992.
36. Shields, A. F., Mankoff, D., Graham, M. M., et al. Analysis of 2-carbon-11-thymidine blood metabolites in PET imaging. J. Nucl. Med., 37: 290-296, 1996.
37. Price, P., and Jones, T. Can positron emission tomography (PET) be used to detect subclinical response to cancer therapy? The EC PET Oncology Concerted Action and the EORTC PET Study Group. Eur. J. Cancer, 31A: 1924-1927, 1995.
38. Shields, A. F., Mankoff, D. A., Link, J. M., et al. Carbon-11-thymidine and FDG to measure therapy response. J. Nucl. Med., 39: 1757-1762, 1998.
39. Clavo, A. C., Brown, R. S., and Wahl, R. L. Fluorodeoxyglucose uptake in human cancer cell lines is increased by hypoxia. J. Nucl. Med., 36: 1625-1632, 1995.
40. Kubota, R., Kubota, K., Yamada, S., et al. Active and passive mechanisms of [fluorine-18]fluorodeoxyglucose uptake by proliferating and prenecrotic cancer cells in vivo: a microautoradiographic study. J. Nucl. Med., 35: 1067-1075, 1994.
41. Uehara, H., Miyagawa, T., Tjuvajev, J., et al. Imaging experimental brain tumors with 1-aminocyclopentane carboxylic acid and α-aminoisobutyric acid: comparison to fluorodeoxyglucose and diethylenetriaminepentaacetic acid in morphologically defined tumor regions. J. Cereb. Blood Flow Metab., 17: 1239-1253, 1997.
42. Eary, J. F., Mankoff, D. A., Spence, A. M., et al. 2-[C-11]thymidine imaging of malignant brain tumors. Cancer Res., 59: 615-621, 1999.
43. Levin, V. A., Fernstermacher, J. D., and Patlak, C. S. Sucrose and inulin space measurements of cerebral cortex in four mammalian species. Am. J. Physiol., 219: 1528-1533, 1970.
44. Patlak, C. S., and Fenstermacher, J. D. Measurements of dog blood-brain transfer constants by ventriculocisternal perfusion. Am. J. Physiol., 229: 877-884, 1975.
45. Hamilton, A. The division of differentiated cells in the central nervous system of the white rat. J. Comp. Neurol., 11: 297-318, 1901.
46. Allen, E. The cessation of mitosis in the central nervous system of the albino rat. J. Comp. Neurol., 22: 547-568, 1912.
47. Altman, J., and Das, G. D. Autoradiographic and histological studies of postnatal neurogenesis. J. Comp. Neurol., 126: 337-389, 1966.
48. Haas, R. J., Werner, J., and Fliedner, T. M. Cytokinetics of neonatal brain cell development in rats as studied by the "complete H-thymidine labelling" method. J. Anal., 107: 421-437, 1970.
49. Bar, T. Patterns of vascularization in the developing cerebral cortex. Ciba Found. Symp., 100: 20-36, 1983.
50. Iannotti, F., Fieschi, C., Alfano, B., et al. Simplified, noninvasive PET measurement of blood-brain barrier permeability. J. Comput. Assisted Tomogr., 11: 390-397, 1987.
51. Jarden, J. O., Dhawan, V., Moeller, J. R., Strother, S. C., and Rottenberg, D. A. The time course of steroid action on blood-to-brain and blood-to-tumor transport of 82Rb: a positron emission tomographic study. Ann. Neurol., 25: 239-245, 1989.
52. Zünkeler, B., Carson, R., Olson, J., Blasberg, R., De Vroom, H., Lutz, R., Saris, S., Wright, D., Kammerer, W., Patronas, N., Dedrick, R., Herscovitch, P., and Oldfield, E. Quantification and pharmacokinetics of blood-brain barrier disruption in humans. J. Neurosurg., 85: 1056-1065, 1996.